TY - JOUR
T1 - Surgical Quality Assurance in COLOR III: Standardization and Competency Assessment in a Randomized Controlled Trial
AU - Tsai, Alice Y. C.
AU - Mavroveli, Stella
AU - Miskovic, Danilo
AU - van Oostendorp, Stefan
AU - Adamina, Michel
AU - Hompes, Roel
AU - Aigner, Felix
AU - Spinelli, Antonino
AU - Warusavitarne, Janindra
AU - Knol, Joep
AU - Albert, Matthew
AU - Nassif, George
AU - Bemelman, Willem
AU - Boni, Luigi
AU - Ovesen, Henrik
AU - Austin, Ralph
AU - Muratore, Andrea
AU - Seitinger, Gerald
AU - Sietses, Colin
AU - Lacy, Antonio M.
AU - Tuynman, Jurriaan B.
AU - Bonjer, H. Jaap
AU - Hanna, George B.
PY - 2019
Y1 - 2019
N2 - OBJECTIVE: The aim of this study was to develop an objective and reliable surgical quality assurance system (SQA) for COLOR III, an international multicenter randomized controlled trial (RCT) comparing transanal total mesorectal excision (TaTME) with laparoscopic approach for rectal cancer. BACKGROUND OF SUMMARY DATA: SQA influences outcome measures in RCTs such as lymph nodes harvest, in-hospital mortality, and locoregional cancer recurrence. However, levels of SQA are variable. METHOD: Hierarchical task analysis of TaTME was performed. A 4-round Delphi methodology was applied for standardization of TaTME steps. Semistructured interviews were conducted in round 1 to identify key steps and tasks, which were rated as mandatory, optional, or prohibited in rounds 2 to 4 using questionnaires. Competency assessment tool (CAT) was developed and its content validity was examined by expert surgeons. Twenty unedited videos were assessed to test reliability using generalizability theory. RESULTS: Eighty-three of 101 surgical tasks identified reached 70% agreement (26 mandatory, 56 optional, and 1 prohibited). An operative guide of standardized TaTME was created. CAT is matrix of 9 steps and 4 performance qualities: exposure, execution, adverse event, and end-product. The overall G-coefficient was 0.883. Inter-rater and interitem reliability were 0.883 and 0.986. To enter COLOR III, 2 unedited TaTME and 1 laparoscopic TME videos were submitted and assessed by 2 independent assessors using CAT. CONCLUSION: We described an iterative approach to develop an objective SQA within multicenter RCT. This approach provided standardization, the development of reliable and valid CAT, and the criteria for trial entry and monitoring surgical performance during the trial.
AB - OBJECTIVE: The aim of this study was to develop an objective and reliable surgical quality assurance system (SQA) for COLOR III, an international multicenter randomized controlled trial (RCT) comparing transanal total mesorectal excision (TaTME) with laparoscopic approach for rectal cancer. BACKGROUND OF SUMMARY DATA: SQA influences outcome measures in RCTs such as lymph nodes harvest, in-hospital mortality, and locoregional cancer recurrence. However, levels of SQA are variable. METHOD: Hierarchical task analysis of TaTME was performed. A 4-round Delphi methodology was applied for standardization of TaTME steps. Semistructured interviews were conducted in round 1 to identify key steps and tasks, which were rated as mandatory, optional, or prohibited in rounds 2 to 4 using questionnaires. Competency assessment tool (CAT) was developed and its content validity was examined by expert surgeons. Twenty unedited videos were assessed to test reliability using generalizability theory. RESULTS: Eighty-three of 101 surgical tasks identified reached 70% agreement (26 mandatory, 56 optional, and 1 prohibited). An operative guide of standardized TaTME was created. CAT is matrix of 9 steps and 4 performance qualities: exposure, execution, adverse event, and end-product. The overall G-coefficient was 0.883. Inter-rater and interitem reliability were 0.883 and 0.986. To enter COLOR III, 2 unedited TaTME and 1 laparoscopic TME videos were submitted and assessed by 2 independent assessors using CAT. CONCLUSION: We described an iterative approach to develop an objective SQA within multicenter RCT. This approach provided standardization, the development of reliable and valid CAT, and the criteria for trial entry and monitoring surgical performance during the trial.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073652466&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/31573984
U2 - 10.1097/SLA.0000000000003537
DO - 10.1097/SLA.0000000000003537
M3 - Article
C2 - 31573984
VL - 270
SP - 768
EP - 774
JO - Annals of Surgery
JF - Annals of Surgery
SN - 0003-4932
IS - 5
ER -